- Fellowship - Memorial Sloan-Kettering Cancer Center (2012-2014), Surgical Oncology
- Residency - UCSF School of Medicine (2005-2012), Surgery
- Medical School - Duke University School of Medicine (2000-2005)
Sam Wang, M.D.
- Surgery - Surgical Oncology
- Stomach/EG Junction Cancer
- Pancreatic Cancer
Biography
Sam Wang, M.D., is an Associate Professor in the Department of Surgery at UT Southwestern Medical Center. He specializes in surgical oncology, and his clinical focus includes cancers of the liver, pancreas, stomach, and bile duct.
Dr. Wang received a B.S. with honors in biological science and an A.B. with high honors in history from Stanford University. He then earned his medical degree at Duke University School of Medicine and completed a residency in general surgery at the University of California, San Francisco. He gained advanced training in complex general surgical oncology through a fellowship at Memorial Sloan Kettering Cancer Center in New York City.
Certified by the American Board of Surgery in complex general surgical oncology, he joined the UT Southwestern faculty in 2014.
Dr. Wang is a surgeon-scientist and a UT Southwestern Disease-Oriented Clinical Scholar. In the lab, he is studying cellular factors that regulate gastric cancer initiation, progression, and response to therapy. In addition, he is studying the molecular mechanisms behind the outcome disparities in Hispanic gastric cancer patients. The goals for his research are to identify new diagnostic and therapeutic strategies to improve outcomes for cancer patients.
In 2022, Dr. Wang received an R37 NCI MERIT Award for Early-Stage Investigators from the National Cancer Institute.
He is a member of several professional organizations, including the Society of Surgical Oncology, the Association for Academic Surgery, the American Association for Cancer Research, and the American College of Surgeons.
Meet Dr. Wang
Surgical Oncologist
As a researcher and clinician at UT Southwestern Medical Center, surgical oncologist Sam Wang, M.D., wants a better future for his patients.
In pursuit of that goal, he strives to translate his research findings to improve the lives of his patients with gastrointestinal cancers of the liver, pancreas, stomach, and bile duct.
He has a particular focus on stomach, liver, and pancreatic cancer. His current research seeks to understand the biology of these malignancies in order to develop new classes of therapy for patients.
The survival rates for patients with these diseases have not improved in the past decades despite marked improvement in diagnostic modalities and surgical techniques. Many patients still present with metastatic disease, and the options for treatment are limited. Dr. Wang wants to change that.
“As a physician as well as a basic scientist, my goal is to make discoveries that are clinically relevant to patients,” he says. “With every project, I think about how it could lead to faster diagnosis or a better therapy. And the time I spend with my patients helps me focus my research on what’s clinically important and helps me better understand what can really make a difference.”
In the operating room, Dr. Wang is skilled in traditional and minimally invasive techniques, including robotics. He evaluates each patient to determine the best surgical approach to his or her tumor and works with the larger GI cancer team to treat patients when surgery is not an immediate option.
Dr. Wang knows that a diagnosis of pancreas cancer or any GI cancer can be frightening. He makes sure he spends time with each of his patients and their families, explaining their disease and dispelling myths about treatments.
“The GI Surgical Oncology team works together to help our patients and their families get through this process,” Dr. Wang says. “In addition to medical or surgical treatment, we also guide and support and let patients know what they can expect. It’s a big team effort.”
Education & Training
Professional Associations & Affiliations
- American College of Surgeons
- Association for Academic Surgery
- Society of Surgical Oncology
- Dallas Country Medical Society
- Texas Medical Association
- Society for Surgery of the Alimentary Tract
- American Association for Cancer Research
Honors & Awards
- R37 NCI MERIT Award for Early-Stage Investigators 2022, National Cancer Institute
- D Magazine Best Doctor 2020
- Texas Monthly Super Doctors, Rising Star 2020
- Jacobson Promising Investigator Award 2019, American College of Surgeons
- Faculty Research Fellowship 2017-2019, American College of Surgeons
- Health Care Disparities Research Award 2017-2019, Society for Surgery of the Alimentary Tract
- Outstanding Mentor 2017, Center for Translational Medicine, UT Southwestern
- Disease-Oriented Clinical Scholar 2015-2018, UT Southwestern
- Conquer Cancer Foundation Merit Award 2014, American Society of Clinical Oncology
- Outstanding Resident Achievement Award 2012, Department of Surgery, University of California, San Francisco
Books & Publications
-
Publications
-
ACTA2 expression predicts survival and is associated with response to immune checkpoint inhibitors in gastric cancer.
Park S, Karalis JD, Hong C, Clemenceau JR, Porembka MR, Kim IH, Lee SH, Wang SC, Cheong JH, Hwang TH, Clinical cancer research : an official journal of the American Association for Cancer Research 2022 Dec -
Arid1a loss potentiates pancreatic β-cell regeneration through activation of EGF signaling.
Celen C, Chuang JC, Shen S, Li L, Maggiore G, Jia Y, Luo X, Moore A, Wang Y, Otto JE, Collings CK, Wang Z, Sun X, Nassour I, Park J, Ghaben A, Wang T, Wang SC, Scherer PE, Kadoch C, Zhu H, Cell reports 2022 Nov 41 5 111581 -
Variation of Hepatocellular Carcinoma Treatment Patterns and Survival Across Geographic Regions in a Veteran Population.
Ju MR, Karalis JD, Chansard M, Augustine MM, Mortensen E, Wang SC, Porembka MR, Zeh HJ, Yopp AC, Polanco PM, Annals of surgical oncology 2022 Aug -
Invited Commentary: Assessing Gastric and Gastroesophageal Junction Cancer Patient Prognosis in the Neoadjuvant Therapy Era.
Karalis JD, Wang SC, Journal of the American College of Surgeons 2022 Aug 235 2 304-305 -
Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population.
Karalis JD, Yoon LY, Hammer STG, Hong C, Zhu M, Nassour I, Ju MR, Xiao S, Castro-Dubon EC, Agrawal D, Suarez J, Reznik SI, Mansour JC, Polanco PM, Yopp AC, Zeh HJ, Hwang TH, Zhu H, Porembka MR, Wang SC, Journal of translational medicine 2022 03 20 1 116 -
Disparities in Guideline-Concordant Treatment and Survival Among Border County Residents With Gastric Cancer.
Ju MR, Wang SC, Mansour JC, Polanco PM, Yopp AC, Zeh HJ, Porembka MR, JCO oncology practice 2022 Feb OP2100431 -
Development and validation of a prognostic and predictive 32-gene signature for gastric cancer.
Cheong JH, Wang SC, Park S, Porembka MR, Christie AL, Kim H, Kim HS, Zhu H, Hyung WJ, Noh SH, Hu B, Hong C, Karalis JD, Kim IH, Lee SH, Hwang TH, Nature communications 2022 02 13 1 774 -
Nativity Status is an Important Social Determinant of Health for Hispanic Patients with Gastric Cancer in Texas.
Ju MR, Karalis JD, Bhat A, Zhu H, Hogan T, Balentine C, Yopp AC, Polanco PM, Wang SC, Zeh HJ, Porembka MR, Annals of surgical oncology 2022 Jan -
Gaps in Providers' Knowledge Delays Gastric Cancer Diagnosis.
Ju MR, Alterio RE, Sawas T, Zeh HJ, Wang SC, Porembka MR, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2022 Jan -
Socioeconomic and racial/ethnic disparities in receipt of palliative care among patients with metastatic hepatocellular carcinoma.
Alterio RE, Ju MR, Wang SC, Mansour JC, Yopp A, Porembka MR, Journal of surgical oncology 2021 Sep -
Treatment and Survival Disparities of Colon Cancer in the Texas-Mexico Border Population: Cancer Disparities in Border Population.
Yan J, Hester CA, Zhu H, Yan J, Augustine MM, Porembka MR, Wang SC, Mansour JC, Iii HJZ, Yopp AC, Polanco PM, The Journal of surgical research 2021 Jul 267 432-442 -
The presentation of Hispanic gastric cancer patients varies by location of patient ancestry.
Karalis JD, Ju MR, Mansour JC, Polanco PM, Yopp AC, Zeh HJ, Porembka MR, Wang SC, Journal of surgical oncology 2021 Jul -
Inaccurate Clinical Stage Is Common for Gastric Adenocarcinoma and Is Associated with Undertreatment and Worse Outcomes.
Ju MR, Karalis JD, Blackwell JM, Mansour JC, Polanco PM, Augustine M, Yopp AC, Zeh HJ, Wang SC, Porembka MR, Annals of surgical oncology 2021 May 28 5 2831-2843 -
Redefining High-Volume Gastric Cancer Centers: The Impact of Operative Volume on Surgical Outcomes.
Ju MR, Blackwell JM, Zeh HJ, Yopp AC, Wang SC, Porembka MR, Annals of surgical oncology 2021 Feb -
Uncovering Biological Factors That Regulate Hepatocellular Carcinoma Growth Using Patient-Derived Xenograft Assays.
Zhu M, Li L, Lu T, Yoo H, Zhu J, Gopal P, Wang SC, Porembka MR, Rich NE, Kagan S, Odewole M, Renteria V, Waljee AK, Wang T, Singal AG, Yopp AC, Zhu H, Hepatology (Baltimore, Md.) 2020 09 72 3 1085-1101 -
Minimally invasive gastrectomy for cancer and anastomotic options.
Ju MR, Wang SC, Zeh HJ, Porembka MR, Journal of surgical oncology 2020 Jul 122 1 49-60 -
Comparative Outcomes of Adenosquamous Carcinoma of the Gallbladder: an Analysis of the National Cancer Database.
Murimwa G, Hester C, Mansour JC, Polanco PM, Porembka MR, Wang SC, Zeh HJ, Yopp AC, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2020 Jul -
Hispanic/Latino Patients with Gastric Adenocarcinoma Have Distinct Molecular Profiles Including a High Rate of Germline CDH1 Variants.
Wang SC, Yeu Y, Hammer STG, Xiao S, Zhu M, Hong C, Clemenceau JR, Yoon LY, Nassour I, Shen J, Agarwal D, Reznik SI, Mansour JC, Yopp AC, Zhu H, Hwang TH, Porembka MR, Cancer research 2020 06 80 11 2114-2124 -
Clinicopathologic Features and Outcomes of Early-Onset Pancreatic Adenocarcinoma in the United States.
Ordonez JE, Hester CA, Zhu H, Augustine M, Porembka MR, Wang SC, Yopp AC, Mansour JC, Zeh HJ, Polanco PM, Annals of surgical oncology 2020 Jun 27 6 1997-2006 -
MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo.
Fiedler LR, Chapman K, Xie M, Maifoshie E, Jenkins M, Golforoush PA, Bellahcene M, Noseda M, Faust D, Jarvis A, Newton G, Paiva MA, Harada M, Stuckey DJ, Song W, Habib J, Narasimhan P, Aqil R, Sanmugalingam D, Yan R, Pavanello L, Sano M, Wang SC, Sampson RD, Kanayaganam S, Taffet GE, Michael LH, Entman ML, Tan TH, Harding SE, Low CMR, Tralau-Stewart C, Perrior T, Schneider MD, Cell stem cell 2020 Mar 26 3 458 -
Multidisciplinary Teams Improve Gastric Cancer Treatment Efficiency at a Large Safety Net Hospital.
Ju M, Wang SC, Syed S, Agrawal D, Porembka MR, Annals of surgical oncology 2020 Mar 27 3 645-650 -
Effect of fragmentation of cancer care on treatment use and survival in hepatocellular carcinoma.
Hester CA, Karbhari N, Rich NE, Augustine M, Mansour JC, Polanco PM, Porembka MR, Wang SC, Zeh HJ, Singal AG, Yopp AC, Cancer 2019 10 125 19 3428-3436 -
Somatic Mutations Increase Hepatic Clonal Fitness and Regeneration in Chronic Liver Disease.
Zhu M, Lu T, Jia Y, Luo X, Gopal P, Li L, Odewole M, Renteria V, Singal AG, Jang Y, Ge K, Wang SC, Sorouri M, Parekh JR, MacConmara MP, Yopp AC, Wang T, Zhu H, Cell 2019 Apr 177 3 608-621.e12 -
Predictors and outcomes of converted minimally invasive pancreaticoduodenectomy: a propensity score matched analysis.
Hester CA, Nassour I, Christie A, Augustine MM, Mansour JC, Polanco PM, Porembka MR, Shoultz TH, Wang SC, Yopp AC, Zeh HJ, Minter RM, Surgical endoscopy 2019 Apr -
Incidence and comparative outcomes of periampullary cancer: A population-based analysis demonstrating improved outcomes and increased use of adjuvant therapy from 2004 to 2012.
Hester CA, Dogeas E, Augustine MM, Mansour JC, Polanco PM, Porembka MR, Wang SC, Zeh HJ, Yopp AC Journal of surgical oncology 2019 03 119 3 303-317 -
Neuroendocrine Tumors in Meckel's Diverticulum: Recommendation for Lymphadenectomy Regardless of Tumor Size Based on the NCDB Experience.
Dogeas E, Magallanes M, Porembka MR, Wang SC, Yopp AC, Polanco PM, Mansour JC, Choti MA, Zeh HJ, Augustine MM Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2019 Jan -
Comparison of Overall Survival Between Preoperative Chemotherapy and Chemoradiotherapy for Resectable Pancreatic Adenocarcinoma.
Mokdad AA, Minter RM, Yopp AC, Porembka MR, Wang SC, Zhu H, Augustine MM, Mansour JC, Choti MA, Polanco PM Journal of the National Comprehensive Cancer Network : JNCCN 2018 Dec 16 12 1468-1475 -
Adjuvant Therapy is Associated with Improved Survival in pT1N1 Gastric Cancer in a Heterogeneous Western Patient Population.
Hester CA, Augustine MM, Mansour JC, Polanco PM, Yopp AC, Zeh HJ, Wang SC, Porembka MR Annals of surgical oncology 2018 Nov -
restrains pancreatic neoplasia formation.
Wang SC, Nassour I, Xiao S, Zhang S, Luo X, Lee J, Li L, Sun X, Nguyen LH, Chuang JC, Peng L, Daigle S, Shen J, Zhu H Gut 2018 Oct -
Improved Survival in Surgically Resected Distal Cholangiocarcinoma Treated with Adjuvant Therapy: a Propensity Score Matched Analysis.
Hester C, Nassour I, Adams-Huet B, Augustine M, Choti MA, Minter RM, Mansour JC, Polanco PM, Porembka MR, Wang SC, Yopp AC Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2018 Jul -
Comparative outcomes of adenosquamous carcinoma of the pancreas: An analysis of the National Cancer Database.
Hester CA, Augustine MM, Choti MA, Mansour JC, Minter RM, Polanco PM, Porembka MR, Wang SC, Yopp AC Journal of surgical oncology 2018 Jun -
Determining the Adequate Examined Lymph Node Count in Resected Ampullary Adenocarcinoma-A National Cohort Study.
Nassour I, Christie A, Choti MA, Mansour JC, Minter RM, Polanco PM, Augustine MM, Porembka MR, Xie XJ, Wang SC Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2018 Mar -
Reply to Grant, William: Obesity and vitamin D status may help explain the racial and ethnic disparities in ampullary cancer survival rates.
Nassour I, Wang SC Journal of surgical oncology 2018 Feb -
Adjuvant Therapy Is Associated With Improved Survival in Resected Perihilar Cholangiocarcinoma: A Propensity Matched Study.
Nassour I, Mokdad AA, Porembka MR, Choti MA, Polanco PM, Mansour JC, Minter RM, Wang SC, Yopp AC Annals of surgical oncology 2018 Feb -
Adoption of evidence-based novel therapies in the treatment of gastric cancer: A national observational study.
Mokdad AA, Ali A, Yopp AC, Polanco PM, Nassour I, Mansour JC, Choti MA, Minter RM, Wang SC, Porembka MR Cancer 2017 Dec -
Reply to "Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Patients With Resectable Gastroesophageal Junction and Gastric Cancer".
Wang SC, Coit DG Annals of surgery 2017 Dec 266 6 e77 -
Robotic-assisted versus laparoscopic pancreaticoduodenectomy: oncological outcomes.
Nassour I, Choti MA, Porembka MR, Yopp AC, Wang SC, Polanco PM Surgical endoscopy 2017 Dec -
Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer.
Sun X, Wang SC, Wei Y, Luo X, Jia Y, Li L, Gopal P, Zhu M, Nassour I, Chuang JC, Maples T, Celen C, Nguyen LH, Wu L, Fu S, Li W, Hui L, Tian F, Ji Y, Zhang S, Sorouri M, Hwang TH, Letzig L, James L, Wang Z, Yopp AC, Singal AG, Zhu H Cancer cell 2017 Nov 32 5 574-589.e6 -
Association of Adjuvant Therapy with Improved Survival in Ampullary Cancer: A National Cohort Study.
Nassour I, Hynan LS, Christie A, Minter RM, Yopp AC, Choti MA, Mansour JC, Porembka MR, Wang SC Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2017 Nov -
Racial and ethnic disparities in a national cohort of ampullary cancer patients.
Nassour I, Mokdad AA, Minter RM, Polanco PM, Augustine MM, Mansour JC, Porembka MR, Wang SC Journal of surgical oncology 2017 Oct -
Adjuvant Chemotherapy vs Postoperative Observation Following Preoperative Chemoradiotherapy and Resection in Gastroesophageal Cancer: A Propensity Score-Matched Analysis.
Mokdad AA, Yopp AC, Polanco PM, Mansour JC, Reznik SI, Heitjan DF, Choti MA, Minter RR, Wang SC, Porembka MR JAMA oncology 2017 Sep -
Conversion of Minimally Invasive Distal Pancreatectomy: Predictors and Outcomes.
Nassour I, Wang SC, Porembka MR, Augustine MM, Yopp AC, Mansour JC, Minter RM, Choti MA, Polanco PM Annals of surgical oncology 2017 Aug -
Robotic Versus Laparoscopic Pancreaticoduodenectomy: a NSQIP Analysis.
Nassour I, Wang SC, Porembka MR, Yopp AC, Choti MA, Augustine MM, Polanco PM, Mansour JC, Minter RM Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2017 Aug -
Nomogram to predict non-home discharge following pancreaticoduodenectomy in a national cohort of patients.
Nassour I, Wang SC, Christie A, Mokdad AA, Porembka MR, Choti MA, Augustine MM, Yopp AC, Xie XJ, Mansour JC, Minter RM, Polanco PM HPB : the official journal of the International Hepato Pancreato Biliary Association 2017 Aug -
Minimally Invasive Versus Open Pancreaticoduodenectomy: A Propensity-Matched Study From a National Cohort of Patients.
Nassour I, Wang SC, Christie A, Augustine MM, Porembka MR, Yopp AC, Choti MA, Mansour JC, Xie XJ, Polanco PM, Minter RM Annals of surgery 2017 May -
The Yield of Staging Laparoscopy in Gastric Cancer is Affected by Racial and Ethnic Differences in Disease Presentation.
Nassour I, Fullington H, Hynan LS, Yopp AC, Augustine MM, Polanco PM, Choti MA, Mansour JC, Wang SC, Porembka MR Annals of surgical oncology 2017 Feb -
Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched Analysis.
Mokdad AA, Minter RM, Zhu H, Augustine MM, Porembka MR, Wang SC, Yopp AC, Mansour JC, Choti MA, Polanco PM Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Sep -
Suppression of the SWI/SNF Component Arid1a Promotes Mammalian Regeneration.
Sun X, Chuang JC, Kanchwala M, Wu L, Celen C, Li L, Liang H, Zhang S, Maples T, Nguyen LH, Wang SC, Signer RA, Sorouri M, Nassour I, Liu X, Xu J, Wu M, Zhao Y, Kuo YC, Wang Z, Xing C, Zhu H Cell stem cell 2016 Apr 18 4 456-66 -
A Pilot Study Evaluating Serum MMP7 as a Preoperative Prognostic Marker for Pancreatic Ductal Adenocarcinoma Patients.
Wang SC, Parekh JR, Porembka MR, Nathan H, D'Angelica MI, DeMatteo RP, Fong Y, Kingham TP, Jarnagin WR, Allen PJ Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2016 Feb -
Precise let-7 expression levels balance organ regeneration against tumor suppression.
Wu L, Nguyen LH, Zhou K, de Soysa TY, Li L, Miller JB, Tian J, Locker J, Zhang S, Shinoda G, Seligson MT, Zeitels LR, Acharya A, Wang SC, Mendell JT, He X, Nishino J, Morrison SJ, Siegwart DJ, Daley GQ, Shyh-Chang N, Zhu H eLife 2015 Oct 4 -
Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma.
Wang SC, Chou JF, Strong VE, Brennan MF, Capanu M, Coit DG Annals of surgery 2015 Apr -
Management of well-differentiated gastrointestinal neuroendocrine tumors metastatic to the liver.
Wang SC, Fidelman N, Nakakura EK Seminars in oncology 2013 Feb 40 1 69-74 -
Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients.
Parekh JR, Wang SC, Bergsland EK, Venook AP, Warren RS, Kim GE, Nakakura EK Pancreas 2012 Aug 41 6 840-4 -
Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression.
Fukuda A, Wang SC, Morris JP, Folias AE, Liou A, Kim GE, Akira S, Boucher KM, Firpo MA, Mulvihill SJ, Hebrok M Cancer cell 2011 Apr 19 4 441-55 -
Complete and safe resection of challenging retroperitoneal tumors: anticipation of multi-organ and major vascular resection and use of adjunct procedures.
Tseng WW, Wang SC, Eichler CM, Warren RS, Nakakura EK World journal of surgical oncology 2011 9 143 -
KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma.
Morris JP, Wang SC, Hebrok M Nature reviews. Cancer 2010 Oct 10 10 683-95 -
Identification of unknown primary tumors in patients with neuroendocrine liver metastases.
Wang SC, Parekh JR, Zuraek MB, Venook AP, Bergsland EK, Warren RS, Nakakura EK Archives of surgery (Chicago, Ill. : 1960) 2010 Mar 145 3 276-80 -
Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice.
Morris JP, Cano DA, Sekine S, Wang SC, Hebrok M The Journal of clinical investigation 2010 Feb 120 2 508-20 -
Activation of cardiac Cdk9 represses PGC-1 and confers a predisposition to heart failure.
Sano M, Wang SC, Shirai M, Scaglia F, Xie M, Sakai S, Tanaka T, Kulkarni PA, Barger PM, Youker KA, Taffet GE, Hamamori Y, Michael LH, Craigen WJ, Schneider MD, The EMBO journal 2004 Sep 23 17 3559-69 -
Telomere attrition and Chk2 activation in human heart failure.
Oh H, Wang SC, Prahash A, Sano M, Moravec CS, Taffet GE, Michael LH, Youker KA, Entman ML, Schneider MD, Proceedings of the National Academy of Sciences of the United States of America 2003 Apr 100 9 5378-83
-
ACTA2 expression predicts survival and is associated with response to immune checkpoint inhibitors in gastric cancer.
Research
- Biomarker discovery to guide cancer care
- Gastric cancer
- Molecular basis for cancer therapy resistance
- Molecular mechanisms behind disparities in cancer outcomes
Clinical Focus
- Stomach/EG Junction Cancer
- Pancreatic Cancer
- Gastrointestinal Cancers
- Liver Cancer
- Gallbladder/Bile Duct (Cholangiocarcinoma) Cancer